TipRanks
Medivir AB (DE:MVR0)
FRANKFURT:MVR0
Germany Market
MVR0
Medivir AB
RESEARCH TOOLSreports

Medivir AB (MVR0) Stock News & Sentiment

0 Followers
Medivir Updates Share Structure Following LTIP 2023 Conversion
Premium
Company Announcements
Medivir Updates Share Structure Following LTIP 2023 Conversion
6d ago
Medivir Bolsters Finances as Fostrox and MIV-711 Advance in Key Phase II Programs
Premium
Company Announcements
Medivir Bolsters Finances as Fostrox and MIV-711 Advance in Key Phase II Programs
2M ago
Medivir Expands Share Capital to Fund MIV-711 Orphan Indication
Premium
Company Announcements
Medivir Expands Share Capital to Fund MIV-711 Orphan Indication
2M ago
Medivir Shareholders Approve Directed Issue to Bolster Drug Development
Premium
Company Announcements
Medivir Shareholders Approve Directed Issue to Bolster Drug Development
3M ago
Medivir secures long-term U.S. patent protection for fostrox–lenvatinib liver cancer combination
Premium
Company Announcements
Medivir secures long-term U.S. patent protection for fostrox–lenvatinib liver cancer combination
3M ago
Premium
Company Announcements
Medivir Expands Share Capital Following First Tranche of Directed Issue
3M ago
Premium
Company Announcements
Medivir Files Disclosure Document for Directed Share Issue on Nasdaq Stockholm
4M ago
More DE:MVR0 News >

MVR0 News on the Web

Medivir Shareholders Approve Directed Issue to Bolster Drug Development
TipRanks News
Bullish
Medivir secures long-term U.S. patent protection for fostrox–lenvatinib liver cancer combination
TipRanks News
Bullish
Medivir Files Disclosure Document for Directed Share Issue on Nasdaq Stockholm
TipRanks News
Neutral
Medivir Raises SEK 140 Million to Accelerate MIV‑711 Development in Rare Pediatric Disease
TipRanks News
Bullish
Medivir Plans SEK 130 Million Directed Share Issue to Advance Rare Pediatric Disease Drug
TipRanks News
Bullish
Medivir Begins Key Phase 2 Trial of Fostrox Combo in Advanced Liver Cancer
TipRanks News
Bullish
Medivir Delays Q1 Report as South Korea Liver Cancer Trial Expands
TipRanks News
Bullish
Medivir Calls 2026 AGM, Details Shareholder Voting Procedures and Capital Structure
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:MVR0
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:MVR0’s Media Buzz Sentiment?
Currently, no data Available
What is DE:MVR0’s weekly average amount of articles?
Currently, no data Available
What is DE:MVR0’s News Sentiment?
100% of articles about DE:MVR0 were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    XERSXeris Pharmaceuticals
    QTTBQ32 Bio
    ABTAbbott Laboratories
    GMABGenmab
    BAYRYBayer
    Showing the stocks with the most bullish news sentiment over the past week